CCDC134 anticorps (AA 11-120) (AbBy Fluor® 647)

N° du produit ABIN887178

Détail du produit anti-CCDC134 anticorps (AbBy Fluor® 647)

Antigène: CCDC134 (Coiled-Coil Domain Containing 134 (CCDC134))

Épitope: AA 11-120

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CCDC134 est conjugé à/à la AbBy Fluor® 647

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Souris

Homologie: Human,Rat,Dog,Cow,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CCDC134

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur CCDC134

Antigène: CCDC134 (Coiled-Coil Domain Containing 134 (CCDC134))

Autre désignation: CCDC134 (CCDC134 Produits)

Synonymes: anticorps dJ821D11.3, anticorps 2310042L06Rik, anticorps AW208859, anticorps si:dkey-167k11.5, anticorps coiled-coil domain containing 134, anticorps si:dkey-167k11.5, anticorps CCDC134, anticorps Ccdc134

Sujet:

Synonyms: CC134_HUMAN, ccdc134, coiled-coil domain containing 134, Coiled-coil domain-containing protein 134, dJ821D11.3, FLJ22349, MGC21013.

Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. CCDC134 (coiled-coil domain containing 134), also known as MGC21013 or FLJ22349, is a 229 amino acid protein encoded by a gene mapping to human chromosome 22.

ID gène: 79879